These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 32791559)
1. Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series. Loughrey MB; McGrath J; Coleman HG; Bankhead P; Maxwell P; McGready C; Bingham V; Humphries MP; Craig SG; McQuaid S; Salto-Tellez M; James JA Histopathology; 2021 Feb; 78(3):401-413. PubMed ID: 32791559 [TBL] [Abstract][Full Text] [Related]
2. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma]. Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256 [No Abstract] [Full Text] [Related]
3. Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer? Marabelli M; Gandini S; Rafaniello PR; Calvello M; Tolva G; Feroce I; Lazzeroni M; Marino E; Dal Molin M; Trovato C; Guerrieri-Gonzaga A; Petz WL; Barberis M; Bertario L; Bonanni B Dig Liver Dis; 2020 Dec; 52(12):1503-1511. PubMed ID: 32620519 [TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes. Hájková N; Bártů MK; Cibula D; Drozenová J; Fabian P; Fadare O; Frühauf F; Hausnerová J; Hojný J; Krkavcová E; Laco J; Lax SF; Matěj R; Méhes G; Michálková R; Němejcová K; Singh N; Stolnicu S; Švajdler M; Zima T; McCluggage WG; Stružinská I; Dundr P Transl Res; 2023 Oct; 260():61-68. PubMed ID: 37244485 [TBL] [Abstract][Full Text] [Related]
6. Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type. Matsubayashi H; Oishi T; Sasaki K; Abe M; Kiyozumi Y; Higashigawa S; Niiya F; Sato J; Ishiwatari H; Imai K; Hotta K; Kishida Y; Takada K; Ono H; Yamazaki K; Yasui H; Kenmotsu H; Kado N; Kagawa H; Shiomi A; Sugiura T; Bando E; Nishimura S; Hatakeyama K; Serizawa M; Harada R; Sugino T Hum Pathol; 2023 May; 135():54-64. PubMed ID: 36596344 [TBL] [Abstract][Full Text] [Related]
7. Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study. Malapelle U; Parente P; Pepe F; De Luca C; Cerino P; Covelli C; Balestrieri M; Russo G; Bonfitto A; Pisapia P; Fiordelisi F; D'Armiento M; Bruzzese D; Loupakis F; Pietrantonio F; Triassi M; Fassan M; Troncone G; Graziano P Cells; 2020 Sep; 9(9):. PubMed ID: 32887373 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature. Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Kastrinos F; Steyerberg EW; Balmaña J; Mercado R; Gallinger S; Haile R; Casey G; Hopper JL; LeMarchand L; Lindor NM; Newcomb PA; Thibodeau SN; Syngal S; Gut; 2013 Feb; 62(2):272-9. PubMed ID: 22345660 [TBL] [Abstract][Full Text] [Related]
12. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer. Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D PeerJ; 2023; 11():e15920. PubMed ID: 37663290 [TBL] [Abstract][Full Text] [Related]
13. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing. Smithgall MC; Remotti H; Hsiao SJ; Mansukhani M; Liu-Jarin X; Fernandes H Hum Pathol; 2022 Jan; 119():41-50. PubMed ID: 34666078 [TBL] [Abstract][Full Text] [Related]
14. Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. Pino MS; Mino-Kenudson M; Wildemore BM; Ganguly A; Batten J; Sperduti I; Iafrate AJ; Chung DC J Mol Diagn; 2009 May; 11(3):238-47. PubMed ID: 19324997 [TBL] [Abstract][Full Text] [Related]
15. [Value of detection of DNA mismatch repair proteins deficiency by immunohistochemistry in predicting tumor microsatellite status]. Qin Y; Liang L; Zheng X; Zheng J; Ye J; Guo L; Zhao F; Shi X Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):704-8. PubMed ID: 26702526 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers. Gilson P; Levy J; Rouyer M; Demange J; Husson M; Bonnet C; Salleron J; Leroux A; Merlin JL; Harlé A Sci Rep; 2020 Oct; 10(1):16386. PubMed ID: 33009475 [TBL] [Abstract][Full Text] [Related]
17. Routine use of MSI testing in colorectal cancer using a proposed algorithm. Ringgaard ML; Steiniche T; Krag SP APMIS; 2024 Sep; 132(9):632-637. PubMed ID: 38873700 [TBL] [Abstract][Full Text] [Related]
18. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654 [TBL] [Abstract][Full Text] [Related]
19. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
20. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]